Lower Beta-Blocker Dose May Boost Survival After Heart Attack
Dosage should be tailored to the needs of individual patients, researchers say.
Dosage should be tailored to the needs of individual patients, researchers say.
CKD is arguably emerging as a major threat to the developing world. The word ‘arguably” is used deliberately because while we know that CKD in the United States affects approximately 5%-10% of the population (Am J Kidney Dis. 2003;41:1-12) and is a major risk factor for CVD and all-cause mortality, similar data from the developing world is unavailable.